Atara Biotherapeutics

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company that is pioneering the development of transformative therapies for patients who are with serious diseases that include hematologic cancers, solid tumors and autoimmune diseases.

Atara aims to deliver treatments to patients with unmet medical need by leveraging its novel allogeneic EBV T-cell platform.

Its platform intends to leverage the biology of EBV T cells to channel the power of immune system and has the potential of treating a broad range of diseases.

Atara is applying its platform to build a robust pipeline with the goal of developing treatments that enhance the quality and longevity of the lives of patients.